A newly developed model that mimics the blood-brain barrier could help researchers more efficiently test drugs to treat a range of neurological diseases.
Researchers discover key elements associated with tumor cells binding to blood vessels. The findings could help develop new treatments to halt the development of brain tumors.
Researchers from the University of Plymouth have discovered the tole PrPC plays in the development of neurofibromatosis 2 tumors. According to the study, the prion protein is overproduced in schwannomas, compared with healthy Schwann cells. This overproduction is a result of Merlin deficiency and contributed to tumor growth in NF2 patients.
Researchers believe their findings could lead to new targets for brain cancer therapies.
According to researchers, targeting multiple angiogenesis pathways simultaneously could help overcome the resistance to anti-angiogenic treatment developed by glioblastoma brain cancer.
Researchers uncover a possible reason as to why astrocytomas don't respond to standard forms of cancer treatment.